Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
about
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalCancer stem cells and signaling pathways in radioresistanceTherapies targeting cancer stem cells: Current trends and future challengesInsights into Chemoresistance of Prostate CancerPI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical applicationAMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation.EMT, CTCs and CSCs in tumor relapse and drug-resistanceEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell propertiesProteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS ApproachAutophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma.Transforming growth factor-β1 regulates epithelial-mesenchymal transition in association with cancer stem-like cells in a breast cancer cell lineEpithelial-mesenchymal transition in prostate cancer: an overview.Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerCandidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathwayChemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transitionmiR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro.Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men.Involvement of RARRES3 in the regulation of Wnt proteins acylation and signaling activities in human breast cancer cellsPhotochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cellsRadiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations.The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.Koschei the immortal and anti-aging drugsmir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1.Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancerMesenchymal stem cells ameliorate inflammatory cytokine-induced impairment of AT-II cells through a keratinocyte growth factor-dependent PI3K/Akt/mTOR signaling pathwayIonizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotypeAIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma PatientsCancer stem cells, a fuzzy evolving concept: a cell population or a cell property?Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.
P2860
Q26740191-D46ED2A3-9726-4933-AA81-F306D615F1E4Q26744536-65D9C9E4-55E8-49B0-AD77-BB9C0563F27DQ26771576-637B5594-6FEF-4577-9BFA-76D739670F05Q26777880-E4A49AD8-7807-4FCC-BE8F-AE7E52C13D89Q26795589-413AA3F6-4A8F-4AE9-A181-7931877A9D81Q26801538-BFEAEDD1-F7F9-4E2F-88B1-34E5A8ECBFACQ27309773-7D34AD97-6464-4C6D-A3C5-8A074CB613F2Q28082935-EBF6AE15-0887-461B-8AA6-267DE9582867Q28087055-FB8957B2-21E7-4C78-9F9C-ED6AE9076ADDQ28547688-0259B2E4-D8D2-4A0F-A781-F374F012100AQ28550766-3E272B14-9218-4C0F-B121-705EA1E2B794Q33751245-CBFC69EC-E0E6-4D32-BF40-A19CBE60BF0CQ33756214-BAFAE1D5-E4A8-43F4-A11E-C14248AFD520Q33798864-C2696DC8-6135-4EC7-B284-EBE7C357C438Q34077263-342FB503-371E-4493-8995-F52F0A981277Q34091442-796F1990-0C6C-4500-9908-D32CB560DE87Q34295621-28E9BBE1-886B-41EE-B6BA-F9EB7B4209F8Q34311253-131B4C0E-6ACF-48A4-9618-3597CCE6DA75Q34514671-0A61EEF9-3514-4084-A828-F70740B0D994Q34932446-DBBF51C6-CCA4-4BA7-A40F-EFADFB74C957Q35051983-57627C9F-BA8D-416E-942B-82C99295C262Q35256915-DF8A92A7-C95C-4572-90DB-40461F424EFFQ35349515-6F210EE2-7FF0-4A62-8C94-ED0A527703A5Q35585820-AC7B9843-FF08-43BE-B6EB-E94E74D1A7B7Q35598363-5D259E9E-AEC5-4C29-AFCF-8C75B9C3308AQ35604311-80C81069-ACF8-4C85-BF2D-489EE2D45F55Q35751948-F488890F-7531-428D-8DBE-6E913BAC90B6Q35850678-B82C6725-E5B2-4EE1-9645-28178E11DC47Q35960093-BEC5D0F6-F14A-4324-8568-774C4414F228Q36241881-00FA5478-9228-4C35-9F31-45A8147BFA47Q36292001-E681E841-A040-4360-B18E-EBA48FB692D2Q36429163-55C2F726-FABB-43EF-B461-89628420D7CAQ36738755-4F1E509C-714F-4EE3-95F6-B27E1F120284Q36817394-7D0031E6-F538-493C-9DB2-C4BF01BC6FC0Q36983775-F0F6CDFC-E3A9-42E5-924E-9291D794D6FDQ37427945-23B536B6-4B75-482D-9397-423EADB6818FQ37525819-C7E80F2C-4702-47EB-AFF7-05506872564FQ37615676-B75390CA-21D5-47EC-8189-DA7407131D5CQ37636751-664FC27E-B90B-41F4-B5C2-43956862529DQ37657753-D290793B-1BDE-48B7-862F-9CA48C2AC79D
P2860
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@en
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@nl
type
label
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@en
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@nl
prefLabel
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@en
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@nl
P2093
P2860
P356
P1476
Acquisition of epithelial-mese ...... ostate cancer radioresistance.
@en
P2093
P2860
P2888
P356
10.1038/CDDIS.2013.407
P577
2013-10-24T00:00:00Z
P5875
P6179
1006916552